Chime Biologics and Waterstone team up to empower ADC development and manufacturing

China-based Chime Biologics, a leading global contract development and manufacturing organisation (CDMO) that enables it...

November 13, 2024 | Wednesday | News
Novotech and Biostar establish strategic partnership following Biostar’s HKEX listing

Novotech, the global full-service clinical Contract Research Organisation (CRO) that partners with biotech companies to ...

November 12, 2024 | Tuesday | News
Ping An Health and Medtronic form strategic partnership

China-based Ping An Healthcare and Technology has established a strategic partnership with Medtronic (Shanghai) Man...

November 11, 2024 | Monday | News
Trump’s Trade Tango Returns: Will China’s Biotech Dance Through Another Round of Tariffs or Stumble?

With Donald Trump’s return to the White House, the U.S.-China trade relationship is once again in the spotlight. T...

November 9, 2024 | Saturday | News
Hong Kong-based Insilico Medicine enters into revolving loan facility of up to $100 M with HSBC

Hong Kong-based Insilico Medicine, a global leading generative artificial intelligence (AI)-driven biotechnology company...

November 5, 2024 | Tuesday | News
Biosynth Biological Technology opens new state-of-the-art facility in China

Switzerland-headquartered Biosynth, a leading developer and supplier of critical raw materials and services for diagnost...

October 31, 2024 | Thursday | News
Korean startup Neurophet secures significant foothold to accelerate entry into China market

South Korea-based startup Neurophet, an artificial intelligence (AI) solution company for brain disease, has secured a s...

October 31, 2024 | Thursday | News
Hong Kong Innovation Center opens to provide one-stop support for early-stage drug discovery

ATLATL Hong Kong Innovation Center, a new state-of-the-art research facility designed to provide immediate, move-in-read...

October 30, 2024 | Wednesday | News
China's WuXi Biologics launches WuXia RidGS for non-antibiotic cell line development

China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has...

October 29, 2024 | Tuesday | News
HELP Therapeutics Secures FDA Approval for Phase I Study of HiCM-188 in Heart Failure Treatment

HELP Therapeutics Co. Ltd, a clinical-stage cell therapy company, announced that the U.S. Food and Drug Administrat...

October 22, 2024 | Tuesday | News
Hong Kong boosts biomedical industry by cultivating interdisciplinary medicine-engineering talent

The Hong Kong Polytechnic University (PolyU) and Sun Yat-sen University (SYSU) have signed a Memorandum of Understanding...

October 18, 2024 | Friday | News
Junshi Biosciences' oncology drug Toripalimab obtains marketing approval in India and Hong Kong SAR

Shanghai Junshi Biosciences Co. and its wholly-owned subsidiary, TopAlliance Biosciences Inc., has announced that toripa...

October 16, 2024 | Wednesday | News
Hong Kong to develop first one-stop acute stroke management model

The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) and the Prince of Wales Hospital (P...

October 15, 2024 | Tuesday | News
Hong Kong-based Akeso Biopharma secures $250 M to propel global expansion of innovative drug pipeline

Akeso Biopharma, headquarterd in Hong Kong, has successfully raised approximately $250 million through a share plac...

October 14, 2024 | Monday | News
China's CanSino receives over $17 M from Bill & Melinda Gates Foundation to accelerate polio vaccine development

China-based CanSino Biologics Inc. has received an additional financial boost, securing a grant exceeding $17 million to...

October 10, 2024 | Thursday | News
AstraZeneca inks billion dollar deal with China's CSPC Pharma to strengthen cardiovascular pipeline

British firm AstraZeneca has entered into an exclusive license agreement with China-based CSPC Pharmaceutical Group (CSP...

October 7, 2024 | Monday | News
Genentech buys China-based Regor's portfolio of next-gen CDK inhibitors for breast cancer treatment for $850 M

China-headquartered Regor Pharmaceuticals has entered into a definitive purchase agreement whereby Genentech, a member o...

October 4, 2024 | Friday | News
Sanyou Bio announces opening of new 10,000-sqm R&D facility in Shanghai

Sanyou Bio recently announced a move into its new 10,000-square-meter R&D building at Shanghai headquarter...

September 29, 2024 | Sunday | News